title: Allogeneic marrow transplantation for treatment of leukemia: results of the Munich Cooperative Group.
authors.forename: H J
authors.initials: HJ
authors.lastname: Kolb
authors.forename: C
authors.initials: C
authors.lastname: Bender-Götze
authors.forename: R J
authors.initials: RJ
authors.lastname: Haas
authors.forename: S
authors.initials: S
authors.lastname: Thierfelder
authors.forename: W
authors.initials: W
authors.lastname: Wilmanns
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D016026:Bone Marrow Transplantation; D003131:Combined Modality Therapy; D005860:Germany, West; D006086:Graft vs Host Disease / Q000517:prevention & control; D006680:HLA Antigens / Q000276:immunology; D006650:Histocompatibility Testing; D006801:Humans; D007165:Immunosuppression Therapy; D007945:Leukemia, Lymphoid / Q000401:mortality / Q000628:therapy*; D007951:Leukemia, Myeloid / Q000401:mortality / Q000628:therapy*; D015470:Leukemia, Myeloid, Acute / Q000401:mortality / Q000628:therapy*; D012306:Risk; D013997:Time Factors; D014019:Tissue Donors
chemical_list: D006680:HLA Antigens